-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca will launch Zefgrovy in the US in the fourth quarter of 2026 to treat non-small cell lung cancer.

Zhitongcaijing·09/01/2026 06:09:05
Listen to the news
AstraZeneca will launch Zefgrovy in the US in the fourth quarter of 2026 to treat non-small cell lung cancer.